Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes

Table 1 Symptomatic responses after transoral incisionless fundoplication with EsophyX^® device

Ref.	6 mo	12 mo	24 mo	36 mo	6 yr
Cadière et al[6], 2008	-	85%	-	-	-
Cadière et al[8], 2009	-	-	93%	-	-
Testoni et al[9], 2010	82%	76%	-	-	-
Velanovich et al[11], 2010	79%	-	-	-	-
Repici et al[12], 2010	55%	47%	-	-	-
Demyttenaere et al[10], 2010	-	53%	-	-	-
Hoppo et al[13], 2010	-	42%	-	-	-
Barnes et al[20], 2011	93%	-	-	-	-
Bell et al[14], 2011	75%	-	-	-	-
Ihde et al[15], 2011	76%	-	-	-	-
Trad et al[18], 2012	-	82%	-	-	-
Testoni et al[21], 2012	-	-	75%	75%	-
Petersen et al[17], 2012	58%	-	-	-	-
Bell et al[23], 2012	86%	-	-	-	-
Muls et al[22]2013	-	77%	-	65%	-
Bell et al[34], 2013	-	82%	-	-	-
Bell et al[25], 2014	-	-	77%-80%	-	-
Trad et al[26], 2015	93%	-	-	-	-
Hunter et al[27], 2015	-	72%	-	-	-
Testoni et al[24], 2015	84%	80%	88%	84%	86%

Table 2 Symptomatic responses after transoral incisionless fundoplication by the MUSE^TM system

Ref.	6 mo	12 mo	24 mo	36 mo	6 yr
Zacheri et al[28], 2015	83%	-	-	-	-
Roy-Shapira et al[29], 2015	-	82%	73%	73%	-